Europäische Kommission erteilt Anti-PD-1-Therapie KEYTRUDA® (Pembrolizumab) von MSD die Zulassung zur Behandlung von Erstlinien- sowie vorbehandelten Patienten mit fortgeschrittenem Melanom Pembrolizumab zeigt im Rahmen einer klinischen Phase-III-Studie verbessertes Gesamtüberleben im Vergleich mit Ipilimumab July 22, 2015 07:00 AM Eastern Daylight Time KENILWORTH, New Jersey–(BUSINESS WIRE)–MSD, in den Vereinigten Staaten und Kanada […]
by Maggie Fox / May.19.2016 / 5:43 AM ET Former President Jimmy Carter answers questions during a news conference at a Habitat for Humanity building, Nov. 2, in Memphis, Tenn. Mark Humphrey / AP file Cancer Drug Used by Pres. Carter Shows Signs of Being a Breakthrough 02:23 The cancer drug that former […]
FDA-approved indications for KEYTRUDA KEYTRUDA is a prescription medicine used to treat: a kind of skin cancer called melanoma. It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma). a kind of lung cancer called non–small cell lung cancer (NSCLC). It may be used alone […]
